We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.97%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.91B
AUM Growth
+$396M
Cap. Flow
+$287M
Cap. Flow %
15.09%
Top 10 Hldgs %
22.25%
Holding
1,595
New
496
Increased
417
Reduced
319
Closed
313

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$12.1M
2
BMBL icon
Bumble
BMBL
+$11.4M
3
NVDA icon
NVIDIA
NVDA
+$10M
4
MRCY icon
Mercury Systems
MRCY
+$6.22M
5
HUM icon
Humana
HUM
+$6.18M

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$14M
2
BEKE icon
KE Holdings
BEKE
+$12.7M
3
BABA icon
Alibaba
BABA
+$11.4M
4
SPLK
Splunk Inc
SPLK
+$11.1M
5
LI icon
Li Auto
LI
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 14.19%
2 Consumer Discretionary 10.36%
3 Healthcare 9.86%
4 Industrials 9.74%
5 Energy 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASLE icon
1201
AerSale
ASLE
$267M
$99.7K 0.01%
13,885
-871
-6% -$8.04K
GDOT icon
1202
Green Dot
GDOT
$750M
$98K 0.01%
10,503
-1,878
-15% -$16.5K
MX icon
1203
Magnachip Semiconductor
MX
$136M
$96.7K 0.01%
17,323
+454
+3% +$2.91K
EGY icon
1204
Vaalco Energy
EGY
$611M
$96.2K 0.01%
13,800
-16,491
-54% -$77.3K
EB
1205
DELISTED
Eventbrite
EB
$96.1K 0.01%
17,535
-2,186
-11% -$15.9K
LYRA
1206
DELISTED
LYRA THERAPEUTICS INC
LYRA
$95.8K 0.01%
+308
New +$82.1K
HTZ icon
1207
Hertz
HTZ
$770M
$94K ﹤0.01%
+12,008
New +$98.3K
DH icon
1208
Definitive Healthcare
DH
$73.1M
$93.5K ﹤0.01%
+11,584
New +$102K
ACRV icon
1209
Acrivon Therapeutics
ACRV
$74.5M
$93K ﹤0.01%
+13,000
New +$60.3K
KZR
1210
DELISTED
Kezar Life Sciences
KZR
$90.9K ﹤0.01%
+10,080
New +$91.8K
GDRX icon
1211
GoodRx Holdings
GDRX
$1.28B
$89.3K ﹤0.01%
12,576
-48,021
-79% -$318K
ASTL icon
1212
Algoma Steel
ASTL
$477M
$89.1K ﹤0.01%
10,500
-12
-0.1% -$101
SVRA icon
1213
Savara
SVRA
$1.16B
$88.5K ﹤0.01%
+17,779
New +$85.9K
QUAD icon
1214
Quad
QUAD
$504M
$87.5K ﹤0.01%
16,484
+4,200
+34% +$22.7K
KLXE icon
1215
KLX Energy Services
KLXE
$45.6M
$86.5K ﹤0.01%
11,171
-9,693
-46% -$86.6K
WHWK
1216
Whitehawk Therapeutics
WHWK
$261M
$85.6K ﹤0.01%
36,597
+10,200
+39% +$19.7K
RPC
1217
Ridgepost Capital
RPC
$961M
$85.3K ﹤0.01%
+10,131
New +$88.8K
EXFY icon
1218
Expensify
EXFY
$235M
$85.2K ﹤0.01%
46,300
-5,000
-10% -$9.49K
ABSI icon
1219
Absci
ABSI
$1.52B
$82.9K ﹤0.01%
+14,600
New +$65.8K
BORR
1220
Borr Drilling
BORR
$1.29B
$82.5K ﹤0.01%
+12,044
New +$79K
BRCC icon
1221
BRC Inc
BRCC
$222M
$81.4K ﹤0.01%
+19,023
New +$78.9K
MAPS
1222
DELISTED
WM TECHNOLOGY INC A
MAPS
$80.9K ﹤0.01%
+60,845
New +$56.3K
ADAG
1223
Adagene
ADAG
$273M
$80.1K ﹤0.01%
+28,620
New +$89.1K
LTRX icon
1224
Lantronix
LTRX
$260M
$79.6K ﹤0.01%
+22,366
New +$110K
OVID icon
1225
Ovid Therapeutics
OVID
$480M
$77.9K ﹤0.01%
+25,555
New +$85.5K

Similar funds

Prelude Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Prelude Capital Management held 1,595 positions worth $1.91B, up 26% from $1.51B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management deployed $287M of net new capital in Q1 2024, opening 496 new positions and adding to 417 existing holdings. Its largest new stake was Mercury Systems: 206,337 shares worth $6.09M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was New Oriental, an estimated $14M trimmed.

  • Prelude Capital Management's largest Q1 2024 buy was Mercury Systems: 206,337 shares worth $6.09M.
  • Prelude Capital Management added most to Baidu in Q1 2024, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q1 2024 reduction was New Oriental, cutting an estimated $14M.
  • Prelude Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $11.1M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.91B portfolio in Q1 2024.
  • Prelude Capital Management opened 496 new positions and closed 313 in Q1 2024.
  • Prelude Capital Management's portfolio value rose 26% quarter-over-quarter to $1.91B.

Based on Prelude Capital Management's 13F filing for Q1 2024, filed 15 May 2024.